Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.76
Peer-review started: October 27, 2017
First decision: November 8, 2017
Revised: November 17, 2017
Accepted: November 21, 2017
Article in press: November 21, 2017
Published online: January 7, 2018
Processing time: 72 Days and 20.2 Hours
Laparoscopy has been widely used in the treatment of colorectal cancer and it has achieved a good radical effect in oncology. However, for the current clinical guidelines, laparoscopic surgery is not recommended in T4 colorectal cancer.
Due to the characteristics of T4 colorectal cancer, laparoscopic complete resection is difficult for the resection of this kind of tumor. The current colorectal studies about laparoscopy have fewer cases of T4 colorectal cancer, and some studies do not enroll any such cases. We tried to collect and analyze the data about laparoscopy in T4 colorectal cancer in order to add evidence-based clinical evidence.
We aimed to analyze the short- and long-term outcomes of proven pathological T4 colorectal cancer patients who underwent complete resection by laparoscopic or open surgery.
We collected and analyzed the data of pT4 colorectal cancer cases at Guangdong General Hospital from 2006 to 2015. All patients were staged according to the AJCC 7th edition manual for colorectal cancer. We compared the laparoscopy (LAP) group and open (OPEN) group in clinical information, surgical and pathological outcomes, postoperative recovery outcomes, and survival.
There were 101 cases in the LAP group and 110 cases in the OPEN group [including15 (12.9%) cases of conversion to open surgery]. Clinical information did not differ between the two groups. In terms of blood loss, postoperative complications, and rate of recovery, the LAP group performed significantly more favorably (P < 0.05). With regard to pT4a/b and combined organ resection, there were significantly more cases in the OPEN group (P < 0.05). The 3- and 5-year overall survival rates were 74.9% and 60.5%, respectively, for the LAP group and 62.4% and 46.5%, respectively, for the OPEN group (P = 0.060). The 3- and 5-year disease-free survival rates were 68.0% and 57.3%, respectively, for the LAP group and 55.8% and 39.8%, respectively, for the OPEN group (P = 0.053). Multivariate analysis showed that IIIB/IIIC stage, lymph node status, and CA19-9 were significant predictors of overall survival. PT4a/b, IIIC stage, histological subtype, CA19-9, and adjuvant chemotherapy were independent factors affecting disease-free survival.
Laparoscopic surgery may be safe and acceptable in the treatment of pathologic T4 colorectal cancer patients with fast recovery outcomes and oncologic outcomes compared with open surgery. We recommend that it can be carried out in experienced centers. It is required to screen the appropriate cases for laparoscopic surgery, optimize the preoperative diagnosis process, and reduce the conversion rate.
Although our study shows that laparoscopy is able to achieve good clinicopathological and oncologic outcomes similar to those of open surgery, this study is only a retrospective study in a single center with a small sample, and the results need to be confirmed by prospective, multi-center and large sample clinical studies.